ArticleNPJ digital medicine2026
Bridging radiology and pathology: domain-generalized cross-modal learning for clinical.
Article in NPJ digital medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Reliable interpretation of clinical imaging requires integrating complementary evidence across modalities, yet most AI systems remain limited by single-modality analysis and poor generalization across institutions. We propose a unified cross-modal framework that bridges mammography and histopathology for breast cancer diagnosis through: (1) a shared vision transformer encoder with lightweight modality-specific adapters, (2) a weakly supervised patient-level contrastive alignment module that learns cross-modal correspondences without pixel-level supervision, (3) domain generalization strategies combining MixStyle augmentation and invariant risk minimization, and (4) causal test-time adaptation for unseen target domains. The model jointly addresses classification, lesion localization, and pathological grading while generating reasoning-guided attention maps that explicitly link suspicious mammographic regions with corresponding histopathological evidence. Evaluated on four public benchmarks (CBIS-DDSM, INbreast, BACH, CAMELYON16/17), the framework consistently outperforms state-of-the-art unimodal, multimodal, and domain generalization baselines, achieving mean AUC of 0.90 under rigorous leave-one-domain-out evaluation and substantially smaller domain gaps (0.03 vs. 0.06-0.10). Visualization and interpretability analyses further confirm that predictions align with clinically meaningful features, supporting transparency and trust. By advancing multimodal integration, cross-institutional robustness, and explainability, this study represents a step toward clinically deployable AI systems for diagnostic decision support.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.